{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:22:15Z","timestamp":1786980135226,"version":"build-2736575974"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s00415-018-9026-1","type":"journal-article","created":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T01:04:49Z","timestamp":1535763889000},"page":"2594-2601","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Effect of anti-seizure drugs on serum S100B in patients with focal seizure: a randomized controlled trial"],"prefix":"10.1007","volume":"265","author":[{"given":"Rituparna","family":"Maiti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biswa Ranjan","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monalisa","family":"Jena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archana","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santanu","family":"Nath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Srinivasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,1]]},"reference":[{"issue":"5","key":"9026_CR1","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/nn.2535","volume":"13","author":"PI Ortinski","year":"2010","unstructured":"Ortinski PI, Dong J, Mungenast A, Yue C, Takano H, Watson DJ, Haydon PG, Coulter DA (2010) Selective induction of astrocytic gliosis generates deficits in neuronal inhibition. Nat Neurosci 13(5):584\u2013591. \n                    https:\/\/doi.org\/10.1038\/nn.2535","journal-title":"Nat Neurosci"},{"issue":"6","key":"9026_CR2","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1002\/jemt.10303","volume":"60","author":"M Rothermundt","year":"2003","unstructured":"Rothermundt M, Peters M, Prehn JH, Arolt V (2003) S100B in brain damage and neurodegeneration. Microsc Res Tech 60(6):614\u2013632. \n                    https:\/\/doi.org\/10.1002\/jemt.10303","journal-title":"Microsc Res Tech"},{"issue":"7","key":"9026_CR3","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/S1357-2725(01)00046-2","volume":"33","author":"R Donato","year":"2001","unstructured":"Donato R (2001) S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol 33(7):637\u2013668","journal-title":"Int J Biochem Cell Biol"},{"issue":"11","key":"9026_CR4","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.1161\/01.STR.31.11.2670","volume":"31","author":"M Herrmann","year":"2000","unstructured":"Herrmann M, Vos P, Wunderlich MT, de Bruijn CH, Lamers KJ (2000) Release of glial tissue-specific proteins after acute stroke: a comparative analysis of serum concentrations of protein S-100B and glial fibrillary acidic protein. Stroke 31(11):2670\u20132677","journal-title":"Stroke"},{"issue":"5","key":"9026_CR5","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1089\/089771501300227297","volume":"18","author":"UE Pleines","year":"2001","unstructured":"Pleines UE, Morganti-Kossmann MC, Rancan M, Joller H, Trentz O, Kossmann T (2001) S-100 beta reflects the extent of injury and outcome, whereas neuronal specific enolase is a better indicator of neuroinflammation in patients with severe traumatic brain injury. J Neurotrauma 18(5):491\u2013498. \n                    https:\/\/doi.org\/10.1089\/089771501300227297","journal-title":"J Neurotrauma"},{"issue":"5","key":"9026_CR6","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1600-0404.2005.00484.x","volume":"112","author":"H Lins","year":"2005","unstructured":"Lins H, Wallesch CW, Wunderlich MT (2005) Sequential analyses of neurobiochemical markers of cerebral damage in cerebrospinal fluid and serum in CNS infections. Acta Neurol Scand 112(5):303\u2013308. \n                    https:\/\/doi.org\/10.1111\/j.1600-0404.2005.00484.x","journal-title":"Acta Neurol Scand"},{"issue":"1","key":"9026_CR7","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.resuscitation.2004.10.011","volume":"65","author":"R Pfeifer","year":"2005","unstructured":"Pfeifer R, Borner A, Krack A, Sigusch HH, Surber R, Figulla HR (2005) Outcome after cardiac arrest: predictive values and limitations of the neuroproteins neuron-specific enolase and protein S-100 and the Glasgow Coma Scale. Resuscitation 65(1):49\u201355. \n                    https:\/\/doi.org\/10.1016\/j.resuscitation.2004.10.011","journal-title":"Resuscitation"},{"issue":"9","key":"9026_CR8","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1161\/STROKEAHA.106.480111","volume":"38","author":"C Foerch","year":"2007","unstructured":"Foerch C, Wunderlich MT, Dvorak F, Humpich M, Kahles T, Goertler M, Alvarez-Sabin J, Wallesch CW, Molina CA, Steinmetz H, Sitzer M, Montaner J (2007) Elevated serum S100B levels indicate a higher risk of hemorrhagic transformation after thrombolytic therapy in acute stroke. Stroke 38(9):2491\u20132495. \n                    https:\/\/doi.org\/10.1161\/STROKEAHA.106.480111","journal-title":"Stroke"},{"key":"9026_CR9","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/S0079-6123(06)61022-4","volume":"161","author":"A Kleindienst","year":"2007","unstructured":"Kleindienst A, Hesse F, Bullock MR, Buchfelder M (2007) The neurotrophic protein S100B: value as a marker of brain damage and possible therapeutic implications. Prog Brain Res 161:317\u2013325. \n                    https:\/\/doi.org\/10.1016\/S0079-6123(06)61022-4","journal-title":"Prog Brain Res"},{"issue":"2","key":"9026_CR10","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s12028-007-9019-x","volume":"8","author":"DL Nash","year":"2008","unstructured":"Nash DL, Bellolio MF, Stead LG (2008) S100 as a marker of acute brain ischemia: a systematic review. Neurocritical Care 8(2):301\u2013307. \n                    https:\/\/doi.org\/10.1007\/s12028-007-9019-x","journal-title":"Neurocritical Care"},{"issue":"4","key":"9026_CR11","doi-asserted-by":"publisher","first-page":"339","DOI":"10.3171\/2009.5.PEDS08481","volume":"4","author":"C Geyer","year":"2009","unstructured":"Geyer C, Ulrich A, Grafe G, Stach B, Till H (2009) Diagnostic value of S100B and neuron-specific enolase in mild pediatric traumatic brain injury. J Neurosurg Pediatr 4(4):339\u2013344. \n                    https:\/\/doi.org\/10.3171\/2009.5.PEDS08481","journal-title":"J Neurosurg Pediatr"},{"issue":"2","key":"9026_CR12","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s00381-009-1009-1","volume":"26","author":"SJ Sandler","year":"2010","unstructured":"Sandler SJ, Figaji AA, Adelson PD (2010) Clinical applications of biomarkers in pediatric traumatic brain injury. Child\u2019s Nerv Syst 26(2):205\u2013213. \n                    https:\/\/doi.org\/10.1007\/s00381-009-1009-1","journal-title":"Child\u2019s Nerv Syst"},{"issue":"1","key":"9026_CR13","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0920-1211(99)00026-1","volume":"36","author":"BJ Steinhoff","year":"1999","unstructured":"Steinhoff BJ, Tumani H, Otto M, Mursch K, Wiltfang J, Herrendorf G, Bittermann HJ, Felgenhauer K, Paulus W, Markakis E (1999) Cisternal S100 protein and neuron-specific enolase are elevated and site-specific markers in intractable temporal lobe epilepsy. Epilepsy Res 36(1):75\u201382","journal-title":"Epilepsy Res"},{"issue":"6","key":"9026_CR14","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1016\/S1734-1140(12)70940-4","volume":"64","author":"M Kacinski","year":"2012","unstructured":"Kacinski M, Budziszewska B, Lason W, Zajac A, Skowronek-Bala B, Leskiewicz M, Kubik A, Basta-Kaim A (2012) Level of S100B protein, neuron specific enolase, orexin A, adiponectin and insulin-like growth factor in serum of pediatric patients suffering from sleep disorders with or without epilepsy. Pharmacol Rep PR 64(6):1427\u20131433","journal-title":"Pharmacol Rep PR"},{"key":"9026_CR15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1471-2377-12-15","volume":"12","author":"CC Chang","year":"2012","unstructured":"Chang CC, Lui CC, Lee CC, Chen SD, Chang WN, Lu CH, Chen NC, Chang AY, Chan SH, Chuang YC (2012) Clinical significance of serological biomarkers and neuropsychological performances in patients with temporal lobe epilepsy. BMC Neurol 12:15. \n                    https:\/\/doi.org\/10.1186\/1471-2377-12-15","journal-title":"BMC Neurol"},{"issue":"2","key":"9026_CR16","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.neulet.2010.08.036","volume":"484","author":"C Lu","year":"2010","unstructured":"Lu C, Li J, Sun W, Feng L, Li L, Liu A, Li J, Mao W, Wei H, Gao L, Zhang X, Huang Z, Meng X, Wang Y (2010) Elevated plasma S100B concentration is associated with mesial temporal lobe epilepsy in Han Chinese: a case\u2013control study. Neurosci Lett 484(2):139\u2013142. \n                    https:\/\/doi.org\/10.1016\/j.neulet.2010.08.036","journal-title":"Neurosci Lett"},{"issue":"2","key":"9026_CR17","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.seizure.2011.10.006","volume":"21","author":"K Mikkonen","year":"2012","unstructured":"Mikkonen K, Pekkala N, Pokka T, Romner B, Uhari M, Rantala H (2012) S100B proteins in febrile seizures. Seizure 21(2):144\u2013146. \n                    https:\/\/doi.org\/10.1016\/j.seizure.2011.10.006","journal-title":"Seizure"},{"issue":"10","key":"9026_CR18","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1046\/j.1528-1157.2002.50101.x","volume":"43","author":"F Leutmezer","year":"2002","unstructured":"Leutmezer F, Wagner O, Baumgartner C (2002) Serum s-100 protein is not a suitable seizure marker in temporal lobe epilepsy. Epilepsia 43(10):1172\u20131174","journal-title":"Epilepsia"},{"issue":"6","key":"9026_CR19","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1034\/j.1600-0404.2003.00159.x","volume":"108","author":"LV Portela","year":"2003","unstructured":"Portela LV, Tort AB, Walz R, Bianchin M, Trevisol-Bittencourt PC, Wille PR, Cardoso RC, Ishida MM, vonWangenheim A, Grisard EC, Steindel M, Goncalves CA, Souza DO (2003) Interictal serum S100B levels in chronic neurocysticercosis and idiopathic epilepsy. Acta Neurol Scand 108(6):424\u2013427","journal-title":"Acta Neurol Scand"},{"issue":"4","key":"9026_CR20","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1111\/j.1528-1167.2010.02522.x","volume":"51","author":"AT Berg","year":"2010","unstructured":"Berg AT, Berkovic SF, Brodie MJ, Buchhalter J, Cross JH, van Emde Boas W, Engel J, French J, Glauser TA, Mathern GW, Moshe SL, Nordli D, Plouin P, Scheffer IE (2010) Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005\u20132009. Epilepsia 51(4):676\u2013685. \n                    https:\/\/doi.org\/10.1111\/j.1528-1167.2010.02522.x","journal-title":"Epilepsia"},{"issue":"10","key":"9026_CR21","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1136\/jnnp.54.10.873","volume":"54","author":"JS Duncan","year":"1991","unstructured":"Duncan JS, Sander JW (1991) The chalfont seizure severity scale. J Neurol Neurosurg Psychiatry 54(10):873\u2013876","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"9026_CR22","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1046\/j.1528-1157.2001.19400.x","volume":"42","author":"JA Cramer","year":"2001","unstructured":"Cramer JA, French J (2001) Quantitative assessment of seizure severity for clinical trials: a review of approaches to seizure components. Epilepsia 42(1):119\u2013129","journal-title":"Epilepsia"},{"issue":"1","key":"9026_CR23","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/j.1528-1157.1998.tb01278.x","volume":"39","author":"JA Cramer","year":"1998","unstructured":"Cramer JA, Perrine K, Devinsky O, Bryant-Comstock L, Meador K, Hermann B (1998) Development and cross-cultural translations of a 31-item quality of life in epilepsy inventory. Epilepsia 39(1):81\u201388","journal-title":"Epilepsia"},{"key":"9026_CR24","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1471-2105-12-77","volume":"12","author":"X Robin","year":"2011","unstructured":"Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC, Muller M (2011) pROC: an open-source package for R and S + to analyze and compare ROC curves. BMC Bioinform 12:77. \n                    https:\/\/doi.org\/10.1186\/1471-2105-12-77","journal-title":"BMC Bioinform"},{"issue":"1","key":"9026_CR25","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0920-1211(96)00051-4","volume":"26","author":"M Khurgel","year":"1996","unstructured":"Khurgel M, Ivy GO (1996) Astrocytes in kindling: relevance to epileptogenesis. Epilepsy Res 26(1):163\u2013175","journal-title":"Epilepsy Res"},{"issue":"2","key":"9026_CR26","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0301-0082(00)00022-8","volume":"63","author":"JL Jankowsky","year":"2001","unstructured":"Jankowsky JL, Patterson PH (2001) The role of cytokines and growth factors in seizures and their sequelae. Prog Neurobiol 63(2):125\u2013149","journal-title":"Prog Neurobiol"},{"issue":"3","key":"9026_CR27","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0167-4889(99)00058-0","volume":"1450","author":"R Donato","year":"1999","unstructured":"Donato R (1999) Functional roles of S100 proteins, calcium-binding proteins of the EF-hand type. Biochimica et Biophysica Acta 1450(3):191\u2013231","journal-title":"Biochimica et Biophysica Acta"},{"issue":"4","key":"9026_CR28","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1097\/00001756-200003200-00030","volume":"11","author":"DS Goncalves","year":"2000","unstructured":"Goncalves DS, Lenz G, Karl J, Goncalves CA, Rodnight R (2000) Extracellular S100B protein modulates ERK in astrocyte cultures. Neuroreport 11(4):807\u2013809","journal-title":"Neuroreport"},{"issue":"6","key":"9026_CR29","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1016\/S0003-4975(99)00425-7","volume":"67","author":"CH Wong","year":"1999","unstructured":"Wong CH, Rooney SJ, Bonser RS (1999) S-100beta release in hypothermic circulatory arrest and coronary artery surgery. Ann Thorac Surg 67(6):1911\u20131914 (discussion 1919\u20131921)","journal-title":"Ann Thorac Surg"},{"issue":"4","key":"9026_CR30","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S0893-133X(99)00037-8","volume":"21","author":"B Lubrich","year":"1999","unstructured":"Lubrich B, van Calker D (1999) Inhibition of the high affinity myo-inositol transport system: a common mechanism of action of antibipolar drugs? Neuropsychopharmacology 21(4):519\u2013529. \n                    https:\/\/doi.org\/10.1016\/S0893-133X(99)00037-8","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"9026_CR31","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s00213-008-1194-8","volume":"200","author":"D Song","year":"2008","unstructured":"Song D, Du T, Li B, Cai L, Gu L, Li H, Chen Y, Hertz L, Peng L (2008) Astrocytic alkalinization by therapeutically relevant lithium concentrations: implications for myo-inositol depletion. Psychopharmacology 200(2):187\u2013195. \n                    https:\/\/doi.org\/10.1007\/s00213-008-1194-8","journal-title":"Psychopharmacology"},{"issue":"1","key":"9026_CR32","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/S0006-8993(99)02371-9","volume":"855","author":"M Wolfson","year":"2000","unstructured":"Wolfson M, Bersudsky Y, Zinger E, Simkin M, Belmaker RH, Hertz L (2000) Chronic treatment of human astrocytoma cells with lithium, carbamazepine or valproic acid decreases inositol uptake at high inositol concentrations but increases it at low inositol concentrations. Brain Res 855(1):158\u2013161","journal-title":"Brain Res"},{"issue":"3","key":"9026_CR33","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s00213-007-0853-5","volume":"194","author":"B Li","year":"2007","unstructured":"Li B, Gu L, Zhang H, Huang J, Chen Y, Hertz L, Peng L (2007) Up-regulation of cPLA(2) gene expression in astrocytes by all three conventional anti-bipolar drugs is drug-specific and enzyme-specific. Psychopharmacology 194(3):333\u2013345. \n                    https:\/\/doi.org\/10.1007\/s00213-007-0853-5","journal-title":"Psychopharmacology"},{"issue":"4","key":"9026_CR34","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.neuropharm.2009.07.004","volume":"57","author":"B Li","year":"2009","unstructured":"Li B, Zhang S, Li M, Zhang H, Hertz L, Peng L (2009) Down-regulation of GluK2 kainate receptor expression by chronic treatment with mood-stabilizing anti-convulsants or lithium in cultured astrocytes and brain, but not in neurons. Neuropharmacology 57(4):375\u2013385. \n                    https:\/\/doi.org\/10.1016\/j.neuropharm.2009.07.004","journal-title":"Neuropharmacology"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-018-9026-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-018-9026-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-018-9026-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T20:24:10Z","timestamp":1567283050000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-018-9026-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,1]]},"references-count":34,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["9026"],"URL":"https:\/\/doi.org\/10.1007\/s00415-018-9026-1","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,1]]},"assertion":[{"value":"26 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The present study have been approved by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}